Peer review of health research funding proposals: A systematic map and systematic review of innovations for effectiveness and efficiency.

Jonathan Shepherd, Geoff K Frampton, Karen Pickett, Jeremy C Wyatt
Author Information
  1. Jonathan Shepherd: Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. ORCID
  2. Geoff K Frampton: Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  3. Karen Pickett: Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  4. Jeremy C Wyatt: Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Abstract

OBJECTIVE: To investigate methods and processes for timely, efficient and good quality peer review of research funding proposals in health.
METHODS: A two-stage evidence synthesis: (1) a systematic map to describe the key characteristics of the evidence base, followed by (2) a systematic review of the studies stakeholders prioritised as relevant from the map on the effectiveness and efficiency of peer review 'innovations'. Standard processes included literature searching, duplicate inclusion criteria screening, study keyword coding, data extraction, critical appraisal and study synthesis.
RESULTS: A total of 83 studies from 15 countries were included in the systematic map. The evidence base is diverse, investigating many aspects of the systems for, and processes of, peer review. The systematic review included eight studies from Australia, Canada, and the USA, evaluating a broad range of peer review innovations. These studies showed that simplifying the process by shortening proposal forms, using smaller reviewer panels, or expediting processes can speed up the review process and reduce costs, but this might come at the expense of peer review quality, a key aspect that has not been assessed. Virtual peer review using videoconferencing or teleconferencing appears promising for reducing costs by avoiding the need for reviewers to travel, but again any consequences for quality have not been adequately assessed.
CONCLUSIONS: There is increasing international research activity into the peer review of health research funding. The studies reviewed had methodological limitations and variable generalisability to research funders. Given these limitations it is not currently possible to recommend immediate implementation of these innovations. However, many appear promising based on existing evidence, and could be adapted as necessary by funders and evaluated. Where feasible, experimental evaluation, including randomised controlled trials, should be conducted, evaluating impact on effectiveness, efficiency and quality.

References

  1. Plast Reconstr Surg. 2015 Feb;135(2):429e-435e [PMID: 25626827]
  2. J Clin Immunol. 1985 Jul;5(4):220-7 [PMID: 4044784]
  3. Health Technol Assess. 2014 Feb;18(15):1-365 [PMID: 24602781]
  4. BMJ Open. 2015 Sep 08;5(9):e009138 [PMID: 26351194]
  5. J Womens Health Gend Based Med. 2002 May;11(4):379-88 [PMID: 12150500]
  6. Ann Intern Med. 2014 Jul 15;161(2):122-30 [PMID: 25023251]
  7. PLoS One. 2012;7(10):e48509 [PMID: 23119041]
  8. Circ Res. 2015 Jul 17;117(3):239-43 [PMID: 26089369]
  9. PLoS One. 2015 Jun 30;10(6):e0130753 [PMID: 26126111]
  10. PLoS One. 2014 Aug 13;9(8):e104244 [PMID: 25119140]
  11. Elife. 2016 Feb 16;5: [PMID: 26880623]
  12. J Cancer Surviv. 2014 Mar;8(1):114-20 [PMID: 24214497]
  13. JAMA. 2004 Feb 18;291(7):836-43 [PMID: 14970062]
  14. PLoS One. 2015 Jun 15;10(6):e0130450 [PMID: 26075884]
  15. Aust N Z J Public Health. 2007 Aug;31(4):372-8 [PMID: 17725020]
  16. Int J Gen Med. 2010 Aug 30;3:225-30 [PMID: 20830198]
  17. PLoS One. 2013 Jun 28;8(6):e68258 [PMID: 23840840]
  18. PLoS Med. 2009 Jul 21;6(7):e1000097 [PMID: 19621072]
  19. J Clin Epidemiol. 2006 Aug;59(8):842-8 [PMID: 16828678]
  20. BMJ Open. 2015 Jul 02;5(7):e008380 [PMID: 26137884]
  21. J Urol. 1995 Nov;154(5):1866-9 [PMID: 7563369]
  22. Ann Surg. 2002 Sep;236(3):277-86; discussion 286-7 [PMID: 12192314]
  23. BMJ Open. 2015 Jan 16;5(1):e006912 [PMID: 25596201]
  24. Clin Res. 1977 Dec;25(5):306-11 [PMID: 10304719]
  25. Syst Rev. 2016 Feb 10;5:28 [PMID: 26864942]
  26. PLoS One. 2010 Nov 17;5(11):e13526 [PMID: 21103331]
  27. Chronic Dis Can. 2003 Spring-Summer;24(2-3):70-4 [PMID: 12959677]
  28. J Clin Epidemiol. 1997 Nov;50(11):1189-95 [PMID: 9393374]
  29. PLoS One. 2015 Apr 01;10(4):e0120838 [PMID: 25830238]
  30. Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11076-80 [PMID: 18663221]
  31. Mol Psychiatry. 2015 Sep;20(9):1030-6 [PMID: 26033238]
  32. PLoS One. 2015 Jun 03;10(6):e0126938 [PMID: 26039440]
  33. FASEB J. 1993 Nov;7(14):1312-9 [PMID: 8224604]
  34. BMC Med. 2010 Oct 20;8:62 [PMID: 20961441]
  35. BMJ. 1995 Oct 21;311(7012):1080-2 [PMID: 7580670]
  36. Eval Rev. 2006 Dec;30(6):803-16 [PMID: 17093109]
  37. Z Gesundh Wiss. 2011 Oct;19(5):445-452 [PMID: 21957333]
  38. Arch Phys Med Rehabil. 1985 May;66(5):318-21 [PMID: 3159374]
  39. J Clin Epidemiol. 2016 Jan;69:147-51 [PMID: 26004515]
  40. South Med J. 2015 Oct;108(10):622-6 [PMID: 26437196]
  41. Circ Res. 2014 Sep 12;115(7):617-24 [PMID: 25214575]
  42. J Natl Cancer Inst. 1979 Oct;63(4):1097-103 [PMID: 480383]
  43. BMC Med Res Methodol. 2016 Jan 05;16:1 [PMID: 26728979]
  44. J Investig Med. 2006 Jan;54(1):13-9 [PMID: 16409886]
  45. J Clin Epidemiol. 2012 Jan;65(1):47-52 [PMID: 21831594]
  46. Health Technol Assess. 2010 Feb;14(7):1-206, iii-iv [PMID: 20178696]
  47. J Public Health Manag Pract. 2013 Jan-Feb;19(1):E9-20 [PMID: 22990496]
  48. Am J Med. 2008 Jul;121(7):637-41 [PMID: 18589061]
  49. Nature. 2010 Sep 23;467(7314):383-5 [PMID: 20864969]
  50. BMJ. 2011 Oct 18;343:d5928 [PMID: 22008217]
  51. PLoS One. 2012;7(9):e46054 [PMID: 23029386]
  52. PLoS One. 2013 Aug 07;8(8):e71693 [PMID: 23951223]
  53. Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000003 [PMID: 17443627]
  54. Braz J Med Biol Res. 1994 Dec;27(12):2709-20 [PMID: 7549995]
  55. F1000Res. 2017 Aug 7;6:1335 [PMID: 29707193]
  56. Public Health Rep. 2013 Nov;128 Suppl 3:61-7 [PMID: 24179281]
  57. J Rheumatol. 1983 Jun;10(3):479-81 [PMID: 6887172]
  58. Health Res Policy Syst. 2009 Feb 13;7:2 [PMID: 19216770]
  59. PLoS One. 2014 Sep 03;9(9):e106474 [PMID: 25184367]
  60. BMJ. 2011 Sep 27;343:d4797 [PMID: 21951756]
  61. Acad Med. 2015 Jan;90(1):69-75 [PMID: 25140529]
  62. Science. 2015 Apr 24;348(6233):434-8 [PMID: 25908820]
  63. Sci Eng Ethics. 2016 Feb;22(1):189-97 [PMID: 25649072]
  64. Can J Cardiol. 1995 Nov;11(10):864-8 [PMID: 7489524]
  65. BMC Health Serv Res. 2015 Feb 07;15:55 [PMID: 25888975]
  66. FASEB J. 1989 Jun;3(8):1987-92 [PMID: 2721858]
  67. JAMA. 1994 Jul 13;272(2):114-6 [PMID: 8015118]

MeSH Term

Biomedical Research
Financial Management
Humans
Peer Review, Research

Word Cloud

Created with Highcharts 10.0.0reviewpeersystematicresearchstudiesprocessesqualityevidencemapfundinghealtheffectivenessefficiencyincludedinnovationskeybasestudymanyevaluatingprocessusingcostsassessedpromisinglimitationsfundersOBJECTIVE:investigatemethodstimelyefficientgoodproposalsMETHODS:two-stagesynthesis:1describecharacteristicsfollowed2stakeholdersprioritisedrelevant'innovations'StandardliteraturesearchingduplicateinclusioncriteriascreeningkeywordcodingdataextractioncriticalappraisalsynthesisRESULTS:total8315countriesdiverseinvestigatingaspectssystemseightAustraliaCanadaUSAbroadrangeshowedsimplifyingshorteningproposalformssmallerreviewerpanelsexpeditingcanspeedreducemightcomeexpenseaspectVirtualvideoconferencingteleconferencingappearsreducingavoidingneedreviewerstravelconsequencesadequatelyCONCLUSIONS:increasinginternationalactivityreviewedmethodologicalvariablegeneralisabilityGivencurrentlypossiblerecommendimmediateimplementationHoweverappearbasedexistingadaptednecessaryevaluatedfeasibleexperimentalevaluationincludingrandomisedcontrolledtrialsconductedimpactPeerproposals:

Similar Articles

Cited By (13)